Rapid Acting Insulin | Vibepedia

Developed through genetic engineering and recombinant DNA technology, rapid-acting insulins represent a significant leap in diabetes management, offering greater flexibility and tighter glycemic control than traditional insulins. Their development has been a cornerstone in the ongoing effort to replicate the body's endogenous insulin secretion patterns, thereby reducing the risk of both hyperglycemia and dangerous hypoglycemic events.